Raymond James & Associates trimmed its position in Inspire Medical Systems, Inc. (NYSE:INSP – Get Rating) by 1.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,690 shares of the company’s stock after selling 221 shares during the quarter. Raymond James & Associates owned 0.05% of Inspire Medical Systems worth $3,700,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust acquired a new stake in Inspire Medical Systems in the first quarter valued at approximately $37,000. Arcadia Investment Management Corp MI acquired a new position in shares of Inspire Medical Systems during the fourth quarter worth $47,000. Harvest Fund Management Co. Ltd lifted its holdings in shares of Inspire Medical Systems by 323.4% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 271 shares of the company’s stock worth $68,000 after purchasing an additional 207 shares during the period. Harel Insurance Investments & Financial Services Ltd. acquired a new position in shares of Inspire Medical Systems during the fourth quarter worth $83,000. Finally, Cowa LLC acquired a new position in shares of Inspire Medical Systems during the third quarter worth $89,000. Institutional investors and hedge funds own 97.04% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have recently commented on INSP shares. KeyCorp lifted their price target on shares of Inspire Medical Systems from $303.00 to $321.00 in a report on Wednesday, May 3rd. UBS Group lifted their price target on shares of Inspire Medical Systems from $300.00 to $304.00 in a report on Wednesday, May 3rd. Truist Financial lifted their price target on shares of Inspire Medical Systems from $335.00 to $360.00 in a report on Thursday, May 18th. Lake Street Capital lifted their price target on shares of Inspire Medical Systems from $250.00 to $305.00 in a report on Wednesday, February 8th. Finally, 92 Resources reissued a “maintains” rating on shares of Inspire Medical Systems in a research note on Wednesday, May 3rd. Eight research analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $312.56.
Insider Buying and Selling at Inspire Medical Systems
Inspire Medical Systems Trading Down 1.1 %
INSP opened at $296.53 on Friday. Inspire Medical Systems, Inc. has a 1-year low of $157.04 and a 1-year high of $314.36. The company has a market cap of $8.60 billion, a P/E ratio of -190.08 and a beta of 1.44. The company has a fifty day moving average price of $264.26 and a two-hundred day moving average price of $252.56.
Inspire Medical Systems (NYSE:INSP – Get Rating) last posted its quarterly earnings results on Tuesday, May 2nd. The company reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.70) by $0.17. Inspire Medical Systems had a negative net margin of 9.35% and a negative return on equity of 10.27%. The firm had revenue of $127.90 million during the quarter, compared to the consensus estimate of $120.06 million. During the same period in the previous year, the firm posted ($0.61) earnings per share. The business’s revenue was up 84.3% compared to the same quarter last year. On average, research analysts forecast that Inspire Medical Systems, Inc. will post -1.18 EPS for the current fiscal year.
Inspire Medical Systems Profile
Inspire Medical Systems, Inc engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead.
- Get a free copy of the StockNews.com research report on Inspire Medical Systems (INSP)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.